BLUE - bluebird bio, Inc.
4.97
0 0%
Share volume: 1,245,197
Last Updated: 05-30-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$4.97
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 09-13-2024 | 09-27-2024 | 11-14-2024 | 03-27-2025 | 05-14-2025 | |
| Total revenue | 18.573 M | 16.101 M | 10.612 M | 38.521 M | 38.712 M | |
| Cost of revenue | 25.864 M | 28.946 M | 11.781 M | 22.789 M | 12.237 M | |
| Gross profit | -7.291 M | -12.845 M | -1.169 M | 15.732 M | 26.475 M | |
| -76.18% | 90.90% | 1,445.77% | 68.29% | |||
| Operating expenses | 71.401 M | 75.547 M | 62.939 M | 52.239 M | 47.982 M | |
| Selling general and admin | 46.329 M | 50.385 M | 39.765 M | 31.395 M | 30.261 M | |
| Research and development | 25.072 M | 25.162 M | 23.174 M | 20.844 M | 17.721 M | |
| Total expenses | 71.401 M | 75.547 M | 65.750 M | 52.190 M | 51.082 M | |
| 5.81% | -12.97% | -20.62% | -2.12% | |||
| Operating income | -78.692 M | -88.392 M | -66.919 M | -36.458 M | -24.607 M | |
| Ebit | -67.527 M | -78.756 M | -56.728 M | -23.273 M | -23.838 M | |
| Pretax income | -69.804 M | -81.372 M | -60.866 M | -28.603 M | -28.969 M | |
| 16.57% | -25.20% | -53.01% | 1.28% | |||
| Income tax | 0.000 | 0.000 | -58.000 K | 128.000 K | 100.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -69.804 M | -81.393 M | -60.808 M | -28.710 M | -29.069 M | |
| -16.60% | 25.29% | 52.79% | -1.25% |